What We're Reading: Page 247
Industry reads hand-picked by our editors
Mar 27, 2019
-
Bloomberg
Tainted Generic Drugs Force FDA to Tighten Safety Regulations
-
STAT
After their baby died, medical bureaucrats deepened their anguish
-
Evaluate
Readouts approach for biggest Huntington's hopes
-
The Washington Post
An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions.
Mar 26, 2019
-
Reuters
Duke University pays $112.5 million in fake research case sparked by whistleblower
-
Chemical & Engineering News
Watch out, CRISPR. The RNA editing race is on
-
Healthcare Dive
Trump admin now backs elimination of ACA in court
-
MarketWatch
Wall Street is ditching amyloid-based Alzheimer’s drugs. They shouldn't, scientists say
Previous
